As scientists race to develop a vaccine to fight the emerging coronavirus, a team from Oxford University says that if their experiments prove the vaccine works, the first doses of it will be ready by next September.
Most of the laboratories that entered this scientific marathon began clinical trials for a few hundred participants to ensure his safety, but the Jenner Institute in Oxford succeeded in laboratory clinical tests, but its effectiveness on the human body will be tested on 6000 people by the end of May, which was considered by the New York Times. "Great Leap" in the race to the expected vaccine.
The website of the American "Al Hurra" channel said that the scientists at Jenner Institute hope that the results will not only reveal that the vaccine is safe, but also seek to know the effectiveness of it in fighting corona, which will give them the green light to start producing and providing the first doses of it at the beginning of the third quarter of this year.
Scientists from the Oxford Institute announced that a million doses of the possible vaccine are being made available in September through 3 manufacturing partners in Britain, two in Europe, one in India and the other in China.
Scientists at the Rocky Mountain Laboratory in Montana tested doses of the vaccine developed by the Oxford Institute on six monkeys of the "macaque rhesus", which was then exposed to the emerging corona virus, and within 28 days they were all fine.
This family of monkeys is a close relative of animals that are very similar to humans. Until now, scientists are still analyzing the results of tests on these monkeys and closely monitoring them to ensure the safety of its testing in humans.
The immunity that a monkey can acquire does not mean that it will apply to humans, but it gives an important indication to scientists, as a Chinese company also says that it has begun testing developed vaccines for 144 people, and that the results were positive, but so far, the Oxford Laboratory's findings are considered " The most advanced "of all the laboratories looking for a vaccine for the emerging corona virus, according to the American newspaper.
Emilio Emini, director of the vaccine program at the Bill & Melinda Gates Foundation that supports several laboratories to develop a Covid-19 vaccine said that clinical tests are very rapid, to find out a possible vaccine that can fight the virus.
He pointed out that the presence of more than one vaccine and clinical trials will give us greater results about what vaccines are required and whether their effectiveness will differ if given to the elderly or young people, not to mention that developing more than one vaccine can reduce the dilemma of bottlenecks in manufacturing.
The number of people infected with Corona virus has reached more than three million people worldwide, of whom more than 211,000 people have died so far.